Publications


Anti-inflammatory, antioxidant, and antiparkinsonian effects of adenosine A2A receptor antagonists. Małgorzata Zygmunt, Krystyna Gołembiowska, Anna Drabczyńska, Katarzyna Kieć-Kononowicz, Jacek Sapa
Pharmacology, biochemistry, and behavior, S0091-3057(15)00061-1 10.1016/j.pbb.2015.02.020
PMID:25735490

Sunday, 12 April 2015
The importance of TRPV1-sensitisation factors for the development of neuropathic pain. Natalia Malek, Agnieszka Pajak, Natalia Kolosowska, Mateusz Kucharczyk, Katarzyna Starowicz
Molecular and cellular neurosciences, 10.1016/j.mcn.2015.02.001 S1044-7431(15)00012-3
PMID:25662734

Friday, 10 April 2015
mGlu₅-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia. Joanna M Wierońska, Natalia Kłeczek, Monika Woźniak, Piotr Gruca, Magdalena Łasoń-Tyburkiewicz, Mariusz Papp, Piotr Brański, Grzegorz Burnat, Andrzej Pilc
Neurochemistry international, 10.1016/j.neuint.2015.03.010 S0197-0186(15)00061-3
PMID:25863284

Wednesday, 8 April 2015
Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats. Agnieszka Wąsik, Irena Romańska, Jerzy Michaluk, Lucyna Antkiewicz-Michaluk
Neurotoxicity research, 10.1007/s12640-015-9523-2
PMID:25711629

Friday, 3 April 2015
Effects of chronic mild stress on the development of drug dependence in rats. Mariusz Papp, Piotr Gruca, Magdalena Lason-Tyburkiewicz, Ewa Litwa, Paul Willner
Behavioural pharmacology, 10.1097/FBP.0000000000000046
PMID:24949570

Tuesday, 31 March 2015
Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression. Mariusz Papp, Piotr Gruca, Magdalena Lasoń-Tyburkiewicz, Nika Adham, Béla Kiss, István Gyertyán
Behavioural pharmacology, 10.1097/FBP.0000000000000070
PMID:25083572

Tuesday, 31 March 2015
Bioisosteric matrices for ligands of serotonin receptors. Dawid Warszycki, Stefan Mordalski, Jakub Staroń, Andrzej J Bojarski
ChemMedChem, 10.1002/cmdc.201402563
PMID:25772514

Monday, 30 March 2015
Brain glucose metabolism in an animal model of depression. J Detka, A Kurek, M Kucharczyk, K Głombik, A Basta-Kaim, M Kubera, W Lasoń, B Budziszewska
Neuroscience, 10.1016/j.neuroscience.2015.03.046 S0306-4522(15)00283-3
PMID:25819664

Wednesday, 25 March 2015
Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans? Grzegorz Kreiner
Frontiers in cellular neuroscience, 10.3389/fncel.2015.00056
PMID:25798086

Monday, 23 March 2015
Pregabalin for the treatment of social anxiety disorder. Paweł Kawalec, Agnieszka Cierniak, Andrzej Pilc, Gabriel Nowak
Expert opinion on investigational drugs, 10.1517/13543784.2014.979283
PMID:25361817

Friday, 13 March 2015